On June 7, Quick-Med Technologies will be presenting their new technology, NIMBUS, to a Congressional caucus on hospital infection prevention in the 21st century as a possible solution to preventing hospital acquired infections.
About NIMBUS:
The NIMBUS technology employs a powerful microbicidal agent that can be permanently bonded to materials such as cotton, rayon or polyurethane to create advanced wound dressings, fabrics or other medical products. The Company has recently announced the finding that NIMBUS is highly effective against key strains of bacteria that have become resistant to antibiotics commonly used to treat infections, including MRSA (Methicillin-Resistant Staphylococcus aureus) and VRE (Vancomycin-Resistant Enterococcus) — two of the most important antibiotic-resistant organisms that cause hospital and nursing home infections.
HA MRSA, MRSA, Nimbus, Research and Development, Washington D.C. .gif)
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.
Leave a Comment